Atrinsic Inc.

PTIX Healthcare Biotechnology

In the quarter to June 2026, EPS grew 61.3% and free cash flow grew 46.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.75 0.05 −6.25%
Market cap
$1.3M
P/E
0.3×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Mar '25 Mar '26
Cash and Short Term Investments
1.69 0.61 0.80 0.67 10.37 7.98 4.06 1.84 0.01 1.51
Receivables
— — — — — — — — 0.07 —
Inventory
— — — — — — — — 0.00 —
Total current assets
1.78 0.70 0.84 0.88 11.06 8.04 4.20 1.88 0.09 1.54
Property, Plant, Equpment (Net)
0.00 0.00 0.00 — — 0.00 0.12 0.07 — 0.01
Goodwill and Intangible Assets (Total)
— — — — — — — — — 2.09
Total non-current assets
0.00 0.00 0.00 — — 0.00 0.12 0.07 — 2.11
Total Assets
1.78 0.70 0.84 0.88 11.06 8.04 4.32 1.96 0.09 3.65
Notes Payable
— — — — — 0.34 — — 1.67 —
Accounts Payable
0.14 0.23 0.87 0.57 0.80 0.78 0.66 0.94 0.96 0.95
Accrued Expenses
— — — — — — — — 0.25 0.08
Other current liabilities
0.43 0.68 0.33 0.08 0.80 0.78 — — 1.38 —
Total current liabilities
0.56 0.91 1.20 0.66 0.80 1.12 0.66 0.94 5.04 1.03
Long Term Debt (Total)
— — 0.28 1.37 0.32 — — — — —
Total non-current liabilities
— — 0.28 1.37 0.32 — — — — —
Total liabilities
0.56 0.91 1.48 2.03 1.12 1.12 0.66 0.94 5.04 1.03
Additional Paid In Capital
12.23 13.36 14.69 16.72 32.41 33.37 34.56 37.45 0.46 6.99
Preferred Stock (Total)
0.00 0.00 0.00 0.00 — — — — — —
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
Retained Earnings
(10.84) (13.40) (15.15) (17.70) (22.22) (25.78) (30.78) (36.30) (5.40) (4.03)
Shareholders Equity (Other)
— — — — — — — — (0.01) (0.34)
Common Equity (Total)
1.22 (0.21) (0.63) (1.15) 9.94 6.92 3.67 1.01 (4.95) 2.62
Shareholders Equity (Total)
1.22 (0.21) (0.63) (1.15) 9.94 6.92 3.67 1.01 (4.95) 2.62
Shareholders Equity and Liabilities (Total)
1.78 0.70 0.84 0.88 11.06 8.04 4.32 1.96 0.09 3.65
Shares (Common)
0.18 0.18 0.18 0.18 0.31 0.31 0.32 0.52 5.80 1.81
Shares (Preferred)
0.02 0.02 0.02 0.02 — — — — 0.02 —
Shareholders Equity (Tangible)
1.22 (0.21) (0.63) (1.15) 9.94 6.92 3.67 1.01 (4.95) 0.53
Net Debt
(1.69) (0.61) (0.52) 0.70 (10.05) (7.98) (4.06) (1.84) (0.01) (1.51)
Total Debt
— — 0.28 1.37 0.32 0.34 — — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 28 Sep 2026